I

Imexpharm Corp
VN:IMP

Watchlist Manager
Imexpharm Corp
VN:IMP
Watchlist
Price: 41 350 VND -0.12% Market Closed
Market Cap: 6.4T VND
Have any thoughts about
Imexpharm Corp?
Write Note

Relative Value

The Relative Value of one IMP stock under the Base Case scenario is 18 990.75 VND. Compared to the current market price of 41 350 VND, Imexpharm Corp is Overvalued by 54%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

IMP Relative Value
Base Case
18 990.75 VND
Overvaluation 54%
Relative Value
Price
I
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
4
vs Industry
40
Median 3Y
1.3
Median 5Y
1.1
Industry
2.5
Forward
2.7
vs History
4
vs Industry
21
Median 3Y
9.7
Median 5Y
8.4
Industry
21.9
Forward
20.4
vs History
12
vs Industry
Median 3Y
5.7
Median 5Y
7.8
Industry
16.5
vs History
7
vs Industry
Median 3Y
9.6
Median 5Y
10.7
Industry
23.6
vs History
4
vs Industry
29
Median 3Y
1
Median 5Y
1
Industry
2.1
vs History
4
vs Industry
39
Median 3Y
1.2
Median 5Y
1
Industry
2.6
Forward
2.6
vs History
4
vs Industry
31
Median 3Y
3.1
Median 5Y
2.6
Industry
5.2
vs History
4
vs Industry
29
Median 3Y
5.5
Median 5Y
4.8
Industry
13.3
Forward
11.9
vs History
4
vs Industry
28
Median 3Y
7
Median 5Y
5.8
Industry
16.6
Forward
15.5
vs History
12
vs Industry
Median 3Y
4.9
Median 5Y
7.7
Industry
15.6
vs History
17
vs Industry
Median 3Y
7.3
Median 5Y
7.3
Industry
19.1
vs History
4
vs Industry
30
Median 3Y
0.9
Median 5Y
0.9
Industry
1.9

Multiples Across Competitors

IMP Competitors Multiples
Imexpharm Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
VN
Imexpharm Corp
VN:IMP
6.4T VND 2.9 25.8 14.1 18.5
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
VN
I
Imexpharm Corp
VN:IMP
Average P/E: 31.6
25.8
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top